Tollbridge Therapeutics is developing innovative therapies that harness the immune system to fight cancer and other diseases. Founded by two leading scientists, including a 2011 Nobel Laureate for Physiology or Medicine, Tollbridge Therapeutics will soon begin animal and human trials on the most promising candidates.